Phase 1b Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed, Transplant-ineligible Multiple Myeloma Patients

  1. Ocio, E.M.
  2. Bringhen, S.
  3. Martinez-Lopez, J.
  4. San-Miguel, J.
  5. Oliva, S.
  6. Rodriguez-Otero, P.
  7. Le Roux, N.
  8. Dong, Y.
  9. Doroumian, S.
  10. Macé, S.
  11. Mateos, M.-V.
Aldizkaria:
HemaSphere

ISSN: 2572-9241

Argitalpen urtea: 2023

Alea: 7

Zenbakia: 2

Orrialdeak: E829

Mota: Gutuna

DOI: 10.1097/HS9.0000000000000829 GOOGLE SCHOLAR lock_openSarbide irekia editor